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Introduction
Oxidative stress is hypothesized to be an important
contributor to the pathophysiology of vascular dis-
eases such as atherosclerosis, hypertension, and dia-
betic microvascular disease (1–4). Reactive oxygen
species (ROS) have been implicated in many aspects of
vascular injury and lesion development, including
lipoprotein oxidation, foam cell formation, smooth
muscle cell (SMC) hypertrophy, and endothelial cell
damage (5, 6). Although ROS generation was original-
ly thought to be limited to phagocytic cells, which con-
tain the prototypical NADPH oxidase, it is now well
accepted that nonphagocytic cell types, such as fibrob-
lasts, glomerular cells, and osteoclasts, also express
components of NADPH oxidase and generate ROS
(7–11). Of particular relevance with respect to vascular
disease, endothelial cells, macrophages, and vascular
SMCs — all components of atherosclerotic lesions —
are also sources of ROS (12–14).
The NADPH oxidase found in phagocytic cells is a
multisubunit complex consisting of cytosolic and
membrane-bound components (15). The membrane-
bound subunits include gp91phox and p22phox, and
comprise the catalytic, flavin-containing portion of the
oxidase. The p47phox subunit is a cytosolic component;
one of the early steps in oxidase activation is phospho-
rylation and translocation of p47phox to the membrane
(16). Although NADPH oxidase is less well character-
ized in nonphagocytic cells, physiologically relevant
generation of ROS and expression of NADPH oxidase
subunits are present in vascular tissue. The vascular
endothelium expresses p22phox, p47phox, and
gp91phox (17, 18). Cultured SMCs express both
p22phox and p47phox (19, 20), and expression of
p22phox, p47phox, p67phox, and gp91phox has been
demonstrated in the vascular adventitia (21). Relevant
to the present study, characterization of the NADPH
oxidase in SMCs has indicated that, in these cells, the
function of the catalytic gp91phox subunit is probably
replaced by a homologue (a member of the nox family)
that has functional and structural similarity to
gp91phox (22, 23).
In addition to differences in expression of oxidase
components, the phagocytic-cell and SMC oxidases dif-
fer with regard to substrate preference and enzyme
activity. The phagocytic-cell oxidase utilizes NADPH
preferentially, whereas SMC and other nonphagocytic-
cell oxidases can also use NADH for ROS generation.
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NADPH oxidase is upregulated in smooth muscle cells (SMCs) in response to growth factor stimu-
lation, concomitant with increased reactive oxygen species (ROS) production. We investigated the
role of ROS production by NADPH oxidase in SMC responses to growth factors and in atheroscle-
rotic lesion formation in ApoE–/– mice. SMCs from wild-type, p47phox–/–, and gp91phox–/– mice dif-
fered markedly with respect to growth factor responsiveness and ROS generation. p47phox–/– SMCs
had diminished superoxide production and a decreased proliferative response to growth factors com-
pared with wild-type cells, whereas the response of gp91phox–/– SMCs was indistinguishable from that
of wild-type SMCs. The relevance of these in vitro observations was tested by measuring atheroscle-
rotic lesion formation in genetically modified (wild-type, p47phox–/–, ApoE–/–, and ApoE–/–/p47phox–/–)
mice. ApoE–/–/p47phox–/– mice had less total lesion area than ApoE–/– mice, regardless of whether mice
were fed standard chow or a high-fat diet. Together, these studies provide convincing support for the
hypothesis that superoxide generation in general, and NADPH oxidase in particular, have a requisite
role in atherosclerotic lesion formation, and they provide a rationale for further studies to dissect the
contributions of ROS to vascular lesion formation.
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Nonphagocytic cells also produce less superoxide (O2–)
after oxidase activation than phagocytic cells do (24).
The low level of ROS generated by the nonphagocytic-
cell enzyme is more apt to alter the redox potential of
the cell and mediate cell signals than to act as a host
defense. Together, these data indicate that the SMC
NADPH oxidases differ from their counterparts in
phagocytic cells, and that the differences in compo-
nents correlate with differences in the cellular func-
tions of these oxidases.
ROS production by the cytosolic NADPH oxidase
complex is a critical signal regulating vascular respons-
es to stimulation. Treatment of SMCs with PDGF or
thrombin induces O2– and hydrogen peroxide (H2O2)
production, and inhibition of ROS production blocks
SMC proliferation (25, 26). In addition, angiotensin
II–induced SMC hypertrophy is dependent on ROS
production (4, 19). Thrombin-stimulated O2– produc-
tion in SMCs increases NADH consumption, which is
inhibited by the flavin-containing enzyme inhibitor
diphenyliodonium (25). Coincident with ROS genera-
tion, p47phox expression and phosphorylation are
increased in SMCs after thrombin stimulation. These
data support the hypothesis that NADPH oxidase is
involved in growth factor–induced SMC proliferation
and suggest that this oxidase system plays an impor-
tant role in atherogenesis.
The experiments described were designed to charac-
terize the role of the p47phox subunit of NADPH oxi-
dase in SMC growth in cultured cells, and to determine
whether deficiency in NADPH oxidase activity alters
atherosclerotic lesion formation in the ApoE–/– murine
model for atherosclerosis. SMCs from mice genetically
deficient in NADPH oxidase (p47phox–/– and
gp91phox–/– mice) were used to resolve the importance
of these two subunits in vascular cell signaling. SMCs
lacking p47phox have attenuated responsiveness to
growth factors in terms of both ROS generation and
growth when compared with wild-type SMCs. Mice
deficient in both ApoE and p47phox were generated to
determine the importance of NADPH oxidase in ath-
erosclerotic lesion formation. Analysis of oil red O–pos-
itive lesions in the aortic tree showed that
ApoE–/–/p47phox–/– mice had decreased lesion area com-
pared with ApoE–/– mice, even though lesions in the
aortic sinus showed no differences, consistent with pre-
vious findings (27, 28).
Methods
Animals and diet. Wild-type C57BL/6J mice, mice defi-
cient in gp91phox, and ApoE-deficient mice were
obtained from The Jackson Laboratory (Bar Harbor,
Maine, USA). The gp91phox-deficient and ApoE-defi-
cient mice were both on C57BL/6J backgrounds.
p47phox-deficient mice were backcrossed four times to
C57BL/6J mice. ApoE–/– mice were bred to p47phox–/–
mice to create mice deficient in both proteins
(ApoE–/–/p47phox–/– mice). Age-matched, sibling male
mice of both ApoE–/– and ApoE–/–/p47phox–/– genotypes
were used. Genotypes were determined by PCR ampli-
fication of tail DNA. Because of concerns that some
p47phox–/– mice had been contaminated with a deletion
at the IFN-γ locus, all mice were genotyped at this locus
and were found to be wild-type. Animals were main-
tained in a 22°C room with a 12-hour light/dark cycle
and given free access to food and water. Mice on a nor-
mal chow diet were maintained on pellet rodent chow
(Harlan Teklad, Madison, Wisconsin, USA) until 30
weeks of age. Mice on the high-fat diet were maintained
on rodent chow until 8 weeks of age, then fed a high-
fat, atherogenic diet (15% fat by weight, Harlan Teklad),
for 10 weeks. Blood was collected by cardiac puncture
in tubes containing EDTA, and the plasma was stored
at –20°C until analysis.
Cell culture. SMCs were isolated from aortas of wild-
type, p47phox–/–, and gp91phox–/– animals. The aortas
were carefully dissected to remove excess connective tis-
sue, then minced and digested in collagenase, elastase,
and soybean trypsin inhibitor (29) at 37°C for 1 hour.
The cells were plated in DMEM containing 10% FCS.
Cells were determined to be SMCs by morphology and
expression of smooth muscle α-actin. RT-PCR and
Western blotting were performed to confirm the
absence of p47phox and gp91phox mRNA and protein
in cells derived from p47phox–/– and gp91phox–/– mice.
3H-thymidine incorporation. SMCs grown to near con-
fluence in six-well plates were made quiescent by serum
starvation. Cells were treated with bovine serum (10%)
or thrombin (2 U/ml) or maintained in serum-free
medium for an additional 24 hours and labeled with
methyl-3H-thymidine at 1 µCi/ml during the last 3
hours of this time period. After labeling, the cells were
washed with PBS and fixed in cold 10% trichloroacetic
acid, and then washed with 95% ethanol. Incorporated
3H-thymidine was extracted in 0.2 M NaOH and meas-
ured in a liquid scintillation counter (30). Values were
expressed as the mean ± SD from six wells, and are rep-
resentative of three separate experiments.
Western blot analysis. Growth-arrested SMCs were
treated with the designated growth factors, and cell
lysates were prepared. Immunoblotting was performed
as described previously (31). Antibodies used were
polyclonal anti-human p47phox (a kind gift of Bernard
Babior, The Scripps Research Institute, La Jolla, Cali-
fornia, USA) and peroxidase-labeled goat anti-rabbit
IgG (Roche Molecular Biochemicals, Indianapolis,
Indiana, USA). Mouse spleen lysate was a positive con-
trol for p47phox expression. Membrane fractions from
SMCs were separated as described (32). Cells were
lysed in a buffer containing 100 mM Tris-HCl, pH 7.4,
and 2% Triton X-100, and the cytoskeleton was pellet-
ed by centrifugation at 15,000 g for 5 minutes. The
supernatant from this centrifugation was centrifuged
at 100,000 g for 2.5 hours. The supernatant from this
centrifugation was considered the cytosol, and the
insoluble pellet was considered the membrane frac-
tion. Immunoblot analysis was performed on fractions
from equivalent numbers of cells. Densitometric
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analyses were performed on at least three individual
experiments, and results are expressed in arbitrary
units as the mean ± SD.
RT-PCR for p47phox. SMCs were growth-arrested in
100-mm culture dishes and treated with or without
thrombin (2 U/ml). Total RNA was isolated by cesium
chloride ultracentrifugation. cDNA was obtained by
transcription of RNA (2 µg) with Moloney murine
leukemia virus reverse transcriptase, and PCR amplifi-
cation was performed with Taq polymerase (Stratagene
Inc., La Jolla, California, USA). For the PCR, a set of
primers generated from the mouse neutrophil p47phox
sequence (33) was used to amplify a 615-bp fragment
of the p47phox gene product (P47-1, 5′-ACAT-
CACAGGCCCCATCATCCTTC-3′; and P47-2, 5′-ATG-
GATTGTCCTTTGTGCC-3′). This fragment contains
sequences coding for amino acids 160–361 of the
mouse neutrophil p47phox protein (33). Simultaneous
amplification was performed with primers specific to
the β-actin gene, generating an 838-bp product, as an
internal control. A cycle number of 30 was chosen for
the PCR, based on preliminary experiments, to ensure
that amplification remained within the linear range.
Band intensities were determined by densitometry.
Experiments were repeated three times, and the results
were expressed as the mean ± SD.
Aconitase and fumarase activity. Aconitase is a citric acid
cycle enzyme that is inactivated by O2– and has been
used as a measure of ROS generation in cultured cells
(34). Cells were plated in 100-mm dishes, made quies-
cent, and treated with growth factors for 1 hour. The
cells were rinsed with ice-cold PBS and scraped into 15-
ml conical tubes in 5 ml of homogenization buffer con-
sisting of 50 mM Tris-HCl (pH 7.6), 1 mM cysteine, 1
mM citrate, and 0.6 mM MnCl2. Cells were pelleted and
transferred to 500 µl of cold homogenization buffer.
The pellet was dispersed by vortexing, and lysed by son-
ication. Lysate (50 µl) was added to 200 µl of assay
buffer (50 mM Tris-HCl (pH7.6), 30 mM citrate, 0.6 mM
MnCl2, 0.2 mM NADP+, and 2 U/ml isocitrate dehydro-
genase) in 96-well plates, in triplicate. Production of
NADPH was determined by reading absorbance at 340
nm every 60 seconds for 60 minutes. Results are aver-
ages of triplicates ± SD and are representative of three
separate experiments. Aconitase activity was normalized
for protein per sample. The specificity of this assay was
confirmed by pretreating cells with polyethylene gly-
col–conjugated superoxide dismutase (10 U/ml) 30
minutes prior to growth factor stimulation. Fumarase
activity in cell lysates was measured by monitoring the
increase in absorbance at 240 nm at 25°C in a 0.1-ml
reaction mixture containing 30 mM potassium phos-
phate (pH 7.4), 0.1 mM EDTA, and 5 mM L-malate.
Immunohistochemistry. Immunostaining for p47phox
and α-actin was performed on mouse aorta sections
fixed in 4% paraformaldehyde. Slides were incubated
with 0.3% H2O2 for 30 minutes and blocked with nor-
mal goat serum in PBS containing 0.1% BSA and 0.1%
Tween 20 for 30 minutes. A 1:100 dilution of anti-
body (or normal rabbit IgG as a control) was applied
to the slides and they were left for 12 hours at 4°C.
Slides were then washed, incubated with goat anti-
rabbit secondary antibody, and processed using the
ABC Staining Kit (Vector Laboratories Inc.,
Burlingame, California, USA). p47phox staining was
visualized with peroxidase using diaminobenzidine as
a chromogen to yield a brown reaction product. For
colocalization experiments, sections were stained with
a monoclonal mouse anti–smooth muscle α-actin
antibody (Novocastra Laboratories Inc., Burlingame,
California, USA), which was detected with a horse
anti-mouse IgG, and visualized with peroxidase using
diaminobenzidine as a chromogen to yield a brown
reaction product. The sections were also stained with
the anti-p47phox antibody as above, and visualized
with Vector Blue (Vector Laboratories Inc.) as a sub-
strate. After counterstaining with hematoxylin, slides
were dehydrated and permanently mounted.
Quantification of atherosclerotic lesions. Atherosclerosis
in the aortas of the various murine models studied
was measured by quantitation of oil red O–positive
lesions that were morphologically consistent with
atherosclerosis. This analysis was performed for
lesions both within the aortic sinus and throughout
the aorta, as described (35, 36). Areas of aortic sinus
lesions were determined by serial sections of fresh-
frozen hearts embedded in OCT medium (Sakura
Finetek, Torrance, California, USA). Sections (10 µm
thick) were taken throughout the aortic sinus (400
µm). Every other section was stained with oil red O
and counterstained with hematoxylin. Lesion area of
the whole aortic tree was also determined. Aortas were
dissected from the heart to the bifurcation (taken
from the same mice that were used for aortic sinus
analysis). The vessels were rinsed in PBS and dissect-
ed to remove connective tissue and attached fat. The
vessels were opened longitudinally and fixed
overnight in 3.7% formaldehyde. Tissues were rinsed
in PBS and stained with oil red O. Whole mounts of
the vessels were prepared, photographed, and digi-
tized. Oil red O–positive lesions were delineated and
analyzed using NIH Image software (NIH, Bethesda,
Maryland, USA). Values are presented as mean ± SD
(n = 12 for each group).
Dihydroethidium labeling of aortas. To measure ROS pro-
duction in vessels in situ, frozen cross sections of aortas
were stained with dihydroethidium (DHE) using a pre-
viously validated method (37, 38). In the presence of
O2–, DHE is converted to the fluorescent molecule
ethidium, which can then label nuclei by intercalating
with DNA. Fresh-frozen cross sections of aorta isolated
from wild-type and p47phox–/– animals (10 µm) were
stained with 10 µM DHE (Molecular Probes Inc.,
Eugene, Oregon, USA) for 5 minutes, rinsed, mounted,
and observed using fluorescent microscopy. Results
were pixilated and quantified using NIH Image soft-
ware, and expressed as the mean ± SD of four aortas
from each strain of mouse.
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Macrophage homing. Macrophages were recruited from
wild-type and p47phox–/– mice by intraperitoneal injec-
tion of thioglycolate. Macrophages were isolated by
attachment to Petri dishes and labeled with fluorescent
microbeads. The labeled macrophages were counted,
and 5 × 105 of them were injected into ApoE–/– mice via
the tail vein. Forty-eight hours later, tissues were har-
vested from the ApoE–/– animals, embedded in OCT,
and snap frozen in liquid nitrogen. Sections were made
through the aorta, and the number of macrophages
attached to or embedded in lesions was determined for
each animal. The liver from each mouse was also dis-
sected and frozen for sectioning to confirm loading of
macrophages into the recipient mouse.
Results
p47phox RNA and protein are present in mouse SMCs and are
regulated by thrombin. We previously reported that inhi-
bition of NADPH oxidase in human SMCs inhibits
thrombin-induced growth signaling (25). To determine
whether a similar NADPH oxidase system was active in
mouse SMCs, we examined whether p47phox mRNA
and protein were expressed in wild-type mouse SMCs.
Mouse p47phox mRNA was detected by RT-PCR in
SMCs (Figure 1a). The basal level of p47phox mRNA
increased within 15 minutes of thrombin stimulation (2
U/ml). This increase reached a maximum 15-fold induc-
tion and was sustained for at least 2 hours after addition
of thrombin. We measured p47phox protein expression
in cellular fractions isolated from SMCs treated with
thrombin by Western blot analysis (Figure 1b). Because
a critical step in activation of the NADPH oxidase pro-
tein complex involves phosphorylation and transloca-
tion of p47phox from the cytosol to the membrane frac-
tion, we investigated whether thrombin induced
p47phox translocation in these SMCs. Membrane and
cytosolic fractions were isolated from wild-type SMCs
treated with thrombin. Within 15 minutes of treatment,
p47phox protein was significantly increased in the mem-
brane fraction. Enrichment of p47phox in the membrane
fraction was maximal at 30 minutes and was coincident
with depletion of p47phox from the cytosol.
Expression of p47phox is necessary for SMC proliferation in
response to thrombin and serum. SMCs isolated from wild-
type, p47phox–/–, and gp91phox–/– animals were exam-
ined in culture to determine whether these NADPH
oxidase subunits are necessary for SMCs to respond to
growth factors. Aortic SMCs were isolated and ampli-
fied in culture. After reaching quiescence, the cells were
treated overnight with either thrombin (2 U/ml) or FBS
(10%). The growth response of the cells was determined
by incorporation of 3H-thymidine as a marker for DNA
replication (Figure 2a). Wild-type SMCs had an approx-
imately threefold greater incorporation of 3H-thymi-
dine in response to both serum and thrombin stimula-
tion than did p47phox–/– SMCs. Interestingly, there was
no difference in growth responses between wild-type
and gp91phox–/– cells after either serum or thrombin
stimulation, consistent with previous observations that
there is a gp91phox homologue present in SMCs (18).
Results of thymidine uptake were confirmed by cell-
count experiments, which demonstrated that the num-
ber of p47phox–/– SMCs was 31% that of wild-type
SMCs after 9 days in culture (Figure 2b).
Growth factor–stimulated ROS production is impaired in
p47phox–/– but not gp91phox–/– cells. Having demonstrated
differences in 3H-thymidine incorporation in cells lack-
ing p47phox, we next investigated whether this correlat-
ed with a decrease in O2– production. O2– production
was determined in cells indirectly by measuring aconi-
tase activity after growth factor treatment (Figure 3a).
p47phox-deficient cells had lower basal levels of O2– pro-
duction (higher aconitase activity) than did wild-type
and gp91phox-deficient cells, and also had attenuated
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Figure 1
(a) RT-PCR of p47phox and β-actin in wild-type SMCs after throm-
bin stimulation (2 U/ml). There is induction of p47phox mRNA by 15
minutes after treatment. The first lane is control RNA from mouse
spleen lysate. Results were quantified by densitometry and expressed
as the mean ± SD of three experiments. *P < 0.05 compared with
untreated SMCs. (b) Western blot analysis of p47phox protein from
membrane and cytosolic fractions of SMCs following thrombin stim-
ulation. Results were quantified by densitometry and expressed as
the mean ± SD from three experiments. *P < 0.05 compared with
untreated cytoplasmic fractions. **P < 0.05 compared with untreat-
ed membrane fractions.
growth factor–responsive O2– production. The reduc-
tion in aconitase activity was inhibited by pretreatment
of cells with superoxide dismutase. The specificity of
these experiments was determined by measuring
fumarase activity, which represents another step in the
citric acid cycle and is insensitive to O2–-induced inacti-
vation. No differences were found between cell types in
either basal or inducible fumarase activity (Figure 3b).
Taken together with our proliferation experiments,
these results support the theory that O2– produced by
NADPH oxidase is necessary for normal SMC response
to growth factors, and that the p47phox subunit of
NADPH oxidase is necessary for SMC response to
growth factor stimulation, whereas the gp91phox pro-
tein is not. Consistent with these observations, we also
found that conversion of DHE to ethidium, a sensitive
marker for O2– generation, was markedly attenuated in
p47phox-deficient cells (see Supplemental Data 1,
www.jci.org/cgi/content/full/108/10/1513/DC1).
Expression of p47phox in aortas of atherosclerotic mice. We
performed immunohistochemical analyses to deter-
mine whether p47phox was also expressed in vascular
cells in vivo. Using a specific anti-p47phox antibody (see
Supplemental Data 2, www.jci.org/cgi/content/
full/108/10/1513/DC2), we found that p47phox expres-
sion is expressed in cells within aortic lesions in ApoE–/–
mice (Figure 4, c and d) and in normal aorta (Figure
4a). Adventitial, and to a lesser extent endothelial,
staining is present in all specimens, and luminal
endothelial cell expression is most prominent in dis-
eased arteries. Staining of mural cells is essentially
absent in nondiseased aortic specimens (Figure 4a), but
is prominent in diseased aortas (Figure 4, b–d). Some
of these cells have large nuclei, are within fibrous
plaques, and do not colocalize with α-actin (yellow
arrows), but do colocalize with macrophage markers
(not shown). Others within the plaque shoulder and in
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Figure 2
Proliferative capacity is decreased in p47phox–/– SMCs compared with wild-type SMCs after growth factor stimulation. (a) Wild-type,
p47phox-, or gp91phox-deficient SMCs were treated with the indicated concentrations of thrombin or serum, and uptake experiments were
performed using thymidine as a marker for DNA synthesis. Results are shown as the mean of six wells ± SD, and are representative of three
separate experiments. *P < 0.05 compared with wild-type SMCs. (b) Growth curve analysis of wild-type, p47phox-, or gp91phox-deficient
SMCs plated at equivalent densities and allowed to proliferate for the indicated time periods. Results are shown as the mean of three wells
± SD and are representative of three separate experiments.
Figure 3
Intracellular ROS production is decreased in p47phox–/– SMCs com-
pared with wild-type SMCs. (a) p47phox-deficient SMCs have signif-
icantly less O2– production, as reflected by attenuation of the
decrease in aconitase activity, following thrombin and serum stimu-
lation (**P < 0.05) than do wild-type SMCs. There is no difference
in O2– production between wild-type and gp91phox-deficient cells.
The reduction in aconitase activity is reversed by pretreatment with
polyethylene glycol–conjugated superoxide dismutase (PEG-SOD).
(b) Fumarase activity was similar in wild-type, p47phox–/–, and
gp91phox–/– SMCs, demonstrating the specificity of the aconitase
assays described in a.
the neointima overlying the plaque are α-actin–positive
and therefore are presumptively SMCs (red arrows).
This upregulation of p47phox expression in SMCs in
situ is consistent with our demonstration of increased
p47phox expression after balloon injury in rats (25).
p47phox–/– aortas have decreased ROS production. Based
on our in vitro observations that p47phox was necessary
for NADPH oxidase activity and growth in SMCs, we
hypothesized that the same phenomena could be
examined in vivo in frozen sections from mouse aortas.
We first demonstrated that frozen sections of aortas
could reduce nitroblue tetrazolium in an NADH-
dependent fashion that was inhibitable by
diphenyliodonium (see Supplemental Data 3,
www.jci.org/cgi/content/full/108/10/1513/DC3),
which indicates that the NADH oxidase is still func-
tional in freshly frozen sections. The capacity for ROS
generation was measured in situ in wild-type and
p47phox–/– aortas using a previously validated assay (37,
38) (Figure 5). Fresh-frozen cross sections of aorta were
incubated with DHE, the conversion of which to ethid-
ium served as a marker for O2–. Wild-type aortas (left
panels) had consistently increased DHE fluorescence
compared with p47phox–/– aortas (right panels), indi-
cating that aortas from p47phox–/– mice had lower basal
production of O2– than did aortas from wild-type mice.
(DHE fluorescence under these conditions was
inhibitable by treatment with superoxide dismutase,
demonstrating the specificity of fluorescence.) Quan-
titative analysis demonstrates that DHE fluorescence
was decreased by 80% in p47phox–/– aortas.
ApoE–/–/p47phox–/– aortas have decreased lesion size com-
pared with ApoE–/– aortas. Our in vitro data, describing
the contributions of NADPH oxidase and intracellular
ROS to SMC proliferation, and the essential role that
SMC growth and migration are felt to contribute to
atherosclerotic lesion formation (39), provide a com-
pelling argument to compare atherosclerotic lesion for-
mation in ApoE–/–/p47phox–/– mice and ApoE–/– mice.
Mice were either maintained on a chow diet for 30
weeks or fed a high-fat “Western” diet for 10 weeks.
Although ApoE–/– mice do develop atherosclerotic
lesions (albeit more slowly) on a normal diet, we felt
that studies using the high-fat diet were necessary in
case p47phox deficiency resulted in a dramatic decrease
in ROS production and lesion formation. To assess
whether our findings resulted from differences in
serum lipid levels, serum cholesterol and triglyceride
levels were determined in wild-type, p47phox–/–,
ApoE–/–, and ApoE–/–/p47phox–/– mice. There was no
effect of p47phox deficiency on serum lipid profiles in
mice maintained on chow or high-fat diets (Table 1).
Lesion size was determined by two methods. Aortic
sinus lesion area was determined by serial sectioning of
the sinus followed by oil red O staining and analysis of
intimal area. This method was chosen because it was
the method used by previous investigators to evaluate
the effect of NADPH oxidase deficiency on lesion size
(27, 28). Because aortic sinus atherosclerosis progress-
es very rapidly in ApoE–/– mice, we also examined ath-
erosclerotic lesions in the aorta, where the progression
is more similar to that observed in human atheroscle-
rosis. Whole aortic lesion area was determined in these
animals by isolation of the aorta from the arch to the
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Figure 4
Expression of p47phox in wild-type and ApoE–/– atherosclerotic arter-
ies. Representative arterial sections from wild-type (a) and ApoE–/–
(b–d) mice. Sections were stained for antibodies against p47phox
alone (a and b, brown chromogen), or simultaneously with anti-
bodies against p47phox (blue) and α-actin (brown). Yellow arrows
indicate cells in the plaque staining positive for p47phox alone, and
red arrows indicate neointimal cells staining positive for both
p47phox and α-actin.
Figure 5
DHE staining is decreased in p47phox-
deficient aortas compared with wild-
type. (a) Fresh-frozen wild-type (left pan-
els) and p47phox-deficient (right panels)
aortas were stained for 10 minutes with
DHE. Results are typical of staining of
sections from four different aortas. (b)
Digital scans of intimal regions of DHE-
stained aortas from wild-type and
p47phox-deficient mice were quantified
using NIH Image software. Results
shown are mean ± SD. *P < 0.05 com-
pared with wild-type aortas.
bifurcation, staining of lesions with oil red O, and
analysis of lesion area on whole mounts of the tissue.
Comparisons were made among wild-type, p47phox–/–,
ApoE–/–, and ApoE–/–/p47phox–/– mice fed either a nor-
mal chow diet or a high-fat diet.
ApoE–/– and ApoE–/–/p47phox–/– mice maintained on
the chow diet (Figure 6) exhibited significant differ-
ences in total aortic lesion area (**P < 0.005). Lack of
the p47phox protein in ApoE–/– mice was associated
with a total mean lesion area that was 75% less than the
mean lesion area in ApoE–/– mice (Figure 6a; represen-
tative aortas shown in Figure 6c). ApoE–/–/p47phox–/–
mice maintained on a high-fat diet for 10 weeks also
had a significantly lower mean lesion area than ApoE–/–
mice on a similar diet (Figure 7a, **P < 0.05). Of inter-
est, and consistent with the findings of others (27, 28),
there were no differences in mean aortic sinus lesion
area between ApoE–/– and ApoE–/–/p47phox–/– mice on
either the chow or the high-fat diet (Figures 6b and 7b).
Recruitment of macrophages to atherosclerotic lesions does
not require macrophage p47phox. To test whether
macrophage recruitment was altered by disruption of
the macrophage NADPH oxidase, macrophages were
recruited from wild-type or p47phox–/– mice, and their
ability to home to atherosclerotic lesions in ApoE–/–
mice was measured at the luminal surface, in plaques
(below the luminal surface), or in total (the sum of the
number in plaques or at the luminal surface). The
number of macrophages homing to lesions per mouse
was compared between wild-type and p47phox–/–
macrophages (Figure 8). The results are shown as the
mean number attached ± SD (n = 10). No differences
were observed in the ability of macrophages from wild-
type or p47phox–/– mice to home to lesions, indicating
that differences in macrophage homing per se do not
account for the phenotypes of p47phox–/–/ApoE–/– mice.
Discussion
It has been hypothesized that oxidative stress is a major
element in the pathophysiology of vascular diseases;
however, direct evidence of this hypothesis is lacking.
Several enzyme systems, including the lipoxygenase,
xanthine oxidase, and NADPH oxidase systems have
been postulated to contribute to ROS generation in
vascular cells (40, 41), but the relative contributions of
each of these oxidase systems is unknown. There are
several pathways by which O2– generated by arterial
cells could promote atherosclerosis. We previously
established that generation of both H2O2 and O2–
occurs rapidly in human SMCs after thrombin stimu-
lation, and that production of ROS is concomitant
with increased NADH consumption and increased
expression of p47phox.
Numerous investigators have demonstrated that
ROS have direct mitogenic effects on vascular cells and
are necessary intermediates for SMC mitogens such as
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Table 1
Blood lipid levels
Serum cholesterol levels (mg/dl ± SD)
Genotype Diet
Chow High fat
Wild-type 52.1 ±14.7 198.2 ± 22.4
p47phox–/– 48.6 ± 21.9 175.3 ± 30.7
ApoE–/– 245 .2 ± 25.6 435.5 ± 26.9
ApoE–/–/p47phox–/– 229.7 ± 33.2 395.1 ± 54.3
Serum triglyceride levels (mg/dl ± SD)
Genotype Diet
Chow High fat
Wild-type 53.4 ± 12.5 93.6 ± 19.2
p47phox–/– 49.5 ± 9.9 83.4 ± 11.8
ApoE–/– 78.7 ± 19.8 157.8 ± 24.5
ApoE–/–/p47phox–/– 68.9 ± 7.3 134.5 ± 40.9
Figure 6
Comparison of oil red O–positive lesion size in mice on chow diet.
Lesions were measured in whole aortas (a) and the aortic sinus (b).
Aortas taken from 30-week-old ApoE–/–/p47phox–/– male mice main-
tained on a normal chow diet had decreased total aortic lesion size
compared with ApoE–/– mice of the same age. There is a decrease of
approximately 75% in lesion size in ApoE–/–/p47phox–/– mice com-
pared with ApoE–/– mice at this age. There is no detectable difference
in atherosclerotic lesion size between these two genotypes when the
aortic sinus lesions are compared (b). Representative oil red
O–stained aortic specimens are shown in (c). **P < 0.005.
PDGF and thrombin (25, 42, 43). The mechanism (or
mechanisms) by which ROS stimulate SMC prolifera-
tion is not clear but may include increased calcium ion
levels, changes in redox state of intracellular proteins,
and/or activation of signaling pathways. Several inves-
tigators have demonstrated that NADPH oxidase is a
necessary component for SMC responses to PDGF and
angiotensin II stimulation (4, 19, 26, 28). In addition to
promoting SMC hypertrophy, O2– production by vas-
cular cells could result in oxidation of LDL, and oxi-
dized LDL is a known atherogenic factor. O2– can also
combine with nitric oxide to form peroxynitrite, a
potent oxidizing species, which can also oxidize LDL.
We report here that expression of a component of
NADPH oxidase, p47phox, is necessary for SMC
response to growth factors and atherosclerotic lesion
formation. Since there is no specific inhibitor for
NADPH oxidase, the role of the enzyme can only be
implicated indirectly from studies utilizing inhibitors.
To overcome this obstacle, and to definitively deter-
mine whether the p47phox subunit of NADPH oxi-
dase is necessary for SMC response to growth factors,
we isolated aortic SMCs from wild-type and p47phox-
deficient mice and compared their responses to
growth factors. We found that p47phox-deficient cells
have a decreased response to both thrombin and
serum, clearly indicating that the oxidase is necessary
for normal growth factor response. Basal and stimu-
lated levels of ROS production in p47phox-deficient
cells are also significantly decreased compared with
wild-type cells. As a point of comparison for these
studies, we also examined SMCs from gp91phox–/–
mice, since gp91 is not required by the SMC NADPH
oxidase. SMCs from gp91phox–/– mice responded to
growth factors and produced ROS at the same level as
did SMCs from wild-type mice. It is likely that in
SMCs, mox1 substitutes for gp91phox in NADPH oxi-
dase (22, 23, 44).
Not only is p47phox an essential component of the
SMC NADPH oxidase, its expression is upregulated by
serum and thrombin in vitro. Interestingly, p47phox
expression is also upregulated by the atherosclerotic
process in vivo. As in our prior study in which we found
increased p47phox protein present in balloon-injured
rat aorta (25), we also found increased p47phox protein
in atherosclerotic mouse aorta. These findings impli-
cate NADPH oxidase in settings in which there is
increased SMC growth.
We determined that p47phox (and NADPH oxidase
activity) was important for atherosclerotic lesion
development by comparing total aortic lesion area in
atherogenic mice versus atherogenic mice deficient in
p47phox. It should be noted that two similar studies
using p47phox–/– and gp91phox–/– animals to deter-
mine whether NADPH oxidase is important in vascu-
lar lesion formation in ApoE–/– mice have been report-
ed (27, 28). In both cases, investigators determined
lesion formation by serial sectioning of the proximal
aorta, predominantly in the area of the aortic sinus.
In both cases, there was no difference observed in ath-
erosclerotic lesion formation between ApoE–/– mice
and either ApoE–/–/p47phox–/– or ApoE–/–/ gp91phox–/–
mice. The major difference in our study was that we
examined lesion formation along the entire length of
the aorta, which allowed us to examine lesion forma-
tion at a much less advanced stage. For example,
under the conditions used in our study, essentially the
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Figure 7
Comparison of oil red O–positive lesion size in mice on a high-fat
diet. Lesions were measured from whole aortas (a) and the aortic
sinus (b). Aortas from 18-week-old ApoE–/–/p47phox–/– male mice
maintained on a high-fat diet for 10 weeks had decreased total aor-
tic lesion size compared with ApoE–/– mice of the same age. There is
an approximately 67% decrease in lesion size in ApoE–/–/p47phox–/–
mice compared with ApoE–/– mice on a high-fat diet. There is no
detectable difference between these two genotypes when the aortic
sinus lesions are compared (b). **P < 0.05.
Figure 8
Comparison of ability of wild-type and p47phox–/– macrophages
(MO) to home to atherosclerotic lesions in plaques, at the luminal
surface, or in total, in ApoE–/– mice. No differences were observed in
homing of macrophages of either genotype to lesions in ApoE–/– mice.
entire aortic sinus develops atherosclerosis in ApoE–/–
mice, while less than 50% of the aortic surface con-
tains oil red O–positive lesions.
By quantitating lesions throughout the aorta, we
found that animals deficient in the p47phox protein in
the ApoE–/– background had decreased total lesion for-
mation compared with ApoE–/– animals, regardless of
diet (chow diet or Western, high-fat diet). However, no
difference in atherosclerotic lesion size was observed at
the aortic sinus. There are at least two possible expla-
nations for our results: (a) if the degree of lesion for-
mation is quite advanced and covers the entire area
examined, it is probably too late a stage to determine
differences in lesion formation, and (b) it is possible
that there are differences between lesion formation at
the aortic sinus and elsewhere in ApoE–/– mice that are
not well understood.
Deletion of the p47phox subunit was not cell- or tis-
sue-specific in these animals; therefore all cell types
involved in lesion formation were affected. This includ-
ed a major cellular component of atherosclerotic
lesions: macrophages and their progeny, foam cells. It
is well known that O2– generation by phagocytic cells is
crucial to host defense but may also be involved in the
pathogenesis of atherosclerosis (2, 45, 46), and the
major source of ROS production in phagocytic cells is
NADPH oxidase. In an attempt to assess this, we also
measured the ability of macrophages deficient in
p47phox to home to atherosclerotic lesions, in compar-
ison with wild-type macrophages. Interestingly,
p47phox-deficient macrophages homed to lesions as
efficiently as wild-type macrophages did, indicating
that alterations of this component of the macrophage
response does not account for differences in lesion for-
mation in p47phox-deficient mice. Although our stud-
ies provide convincing evidence for involvement of the
vascular NADPH oxidase in atherosclerosis, and
demonstrate specific phenotypic defects in p47phox–/–
SMCs, further studies will be required to determine the
contributions of the oxidase in other cell types to the
overall vascular response.
In summary, the studies reported here indicate that
NADPH oxidase is necessary for normal atherogenic
lesion progression in ApoE–/– mice. Although epi-
demiologic studies in humans and in vitro experi-
mental studies have provided a rationale for examin-
ing the role of ROS generation in atherosclerosis, until
now there has been little data from in vivo studies to
support the general hypothesis that ROS in general,
and specifically NADPH oxidase, is required for the
atherogenic phenotype. Although deficiency of essen-
tial components of the oxidase does not eliminate
lesion formation, it significantly reduces total lesion
size throughout the length of the aorta. We have also
established the necessity of NADPH oxidase in serum-
and thrombin-induced SMC proliferation. SMC
hypertrophy is a well-established component of
atherogenic lesion formation, and NADPH oxidase
can be activated by many factors that have roles in the
formation of vascular lesions in vivo, including PDGF,
angiotensin II, arachidonic acid, and phosphatidic
acid. Long-term production of ROS by NADPH oxi-
dase in SMCs and other vascular cells could result in
sustained mitogenic effects of growth factors and sig-
nificant pathophysiology, and ultimately in accelerat-
ed atherosclerotic lesion formation.
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